TA
FSTX

TLS Advisors’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

TLS Advisors’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-54,298
Closed -$343K – 21
2022
Q4 		$343K Buy
+54,298
New +$301K 1.69% 11

TLS Advisors's FSTX Position: Q1 2023 in Review

TLS Advisors sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 54,298 shares — an estimated $343K sold.

TLS Advisors first reported a position in FSTX in Q4 2022 and held it in 1 quarter. The position peaked at $343K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • TLS Advisors reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • TLS Advisors sold 54,298 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $343K.
  • TLS Advisors first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • TLS Advisors's F-star Therapeutics, Inc. Common Stock position peaked at $343K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on TLS Advisors's 13F filing for Q1 2023, filed 16 Nov 2023.